Attempts to find private financing to build a new nuclear reactor in the Netherlands for the production of medical isotopes have failed, health minister Tamara van Ark has told MPs.
The minister said that ‘at this moment’ she sees no option to secure private financing for the Pallas project, which was the government’s intention.
The current reactor at Petten in Noord Holland is 60 years old and now reaching the end of its life.
Petten produces 30% of the global supplies and 70% of European supplies of medical isotopes, which are used in the treatment of cancer and other serious diseases.
The Dutch government decided in 2012 that the current reactor should be replaced and preparations for the new reactor, known as Pallas, are now underway.
The government has so far invested €148m in the project and extended a further €18m credit guarantee to the project while a financial decision is taken about what to do next.
‘The additional loan enables Pallas to continue working on finalising the basic design of the reactor, applying for various permits and preparing for construction,’ the organisation said.
One option, Van Ark said, may be offered by American company Shine which is working on a new method of producing medical isotopes and is also considering setting up a production location in Groningen. However, that is likely to be some years off.
Van Ark said she hopes that a decision can be taken in spring 2021.
Thank you for donating to DutchNews.nl
The DutchNews.nl team would like to thank all the generous readers who have made a donation in recent weeks. Your financial support has helped us to expand our coverage of the coronavirus crisis into the evenings and weekends and make sure you are kept up to date with the latest developments.
DutchNews.nl has been free for 14 years, but without the financial backing of our readers, we would not be able to provide you with fair and accurate news and features about all things Dutch. Your contributions make this possible.